3D-Printed Self-Emulsifying Drug Delivery Systems (SEDDS) for Personalized Oral Drug Delivery: Manufacturing Challenges and Regulatory Perspectives
Year: 2026
Type: article
Abstract: Self-Emulsifying Drug Delivery Systems (SEDDS) are widely used to enhance the oral bioavailability of poorly water-soluble Biopharmaceutics Classification System (BCS) Class II and IV drugs, but conventional liquid-filled capsule formats offer limited flexibility for individualized dosing. Three-dimensional (3D) printing has emerged as a promising technology for producing patient-specific dosage forms with precise control over dose, geometry, and release profile, and its convergence with SEDDS technology represents a novel and largely underexplored area of pharmaceutical research. This review examines the principal additive manufacturing platforms applied to SEDDS integration, including semi-solid extrusion, vat photopolymerization (stereolithography/digital light processing), fused deposition modeling, and inkjet/binder jetting, along with the strategies used to render inherently liquid or semi-solid SEDDS formulations printable. The personalization advantages of this approach, including precise dose titration, polypharmacy consolidation, and pediatric and geriatric dosing applications, are discussed alongside the significant manufacturing challenges that remain, including thermal and photochemical stability, rheological constraints, content uniformity, storage stability, and scale-up limitations. Particular attention is given to the regulatory landscape governing this emerging product class, where existing guidance remains centered on centralized, fixed-formulation manufacturing and has not yet established harmonized, product-specific standards for feedstock qualification, process validation, or decentralized point-of-care production. Continued progress in both formulation science and regulatory framework development will be necessary to translate 3D-printed SEDDS from proof-of-concept research toward clinical application in truly individualized oral drug therapy.
Author: Priyadharshini R.
Institution: University of Nottingham
Language: English
Subfield: Industrial and Manufacturing Engineering
Field: Engineering
Domain: Physical Sciences
Keywords: self-emulsifying drug delivery systems, 3D printing, personalized medicine, oral drug delivery, poorly water-soluble drugs, BCS Class II and IV drugs, additive manufacturing, stereolithography, fused deposition modeling, semi-solid extrusion, regulatory framework, process validation, point-of-care manufacturing, bioavailability enhancement
Open Access status: green
OpenAlex ID: W7235646379
